Trials / Terminated
TerminatedNCT03705013
Observational Study of Sub-populations From Cologuard Post-Approval Study (2014-01)
Observational Study of Sub-populations From "A Longitudinal Study of Cologuard in an Average Risk Population Assessing a Three Year Test Interval"/Protocol 2014-01 Post-Approval Study
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 51 (actual)
- Sponsor
- Exact Sciences Corporation · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The primary endpoint is to obtain longitudinal information on four sub-populations from the Cologuard Post-Approval Study.
Detailed description
Subjects who consented to enroll in Exact Sciences Protocol 2014-01, that fit one of the following sub-populations, will be asked to participate in the sub-study. Population 1 includes those whose Cologuard T0 result was positive and colonoscopy result was negative. Population 2 includes those whose Cologuard T0 result was positive and subject declined to complete a colonoscopy per protocol. Population 3 includes those whose Cologuard result at T3 was positive and colonoscopy result at T3 was negative. Population 4 includes those whose Cologuard result at T3 was positive and subject declined to complete a colonoscopy per protocol. Subjects that enrolled in the Exact Sciences Protocol 2014-01, who provided written informed consent to participate in this sub-study, will asked to complete the Follow-Up Questionnaire during a phone interview.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Cologuard | Observational |
Timeline
- Start date
- 2018-10-30
- Primary completion
- 2019-11-16
- Completion
- 2019-11-16
- First posted
- 2018-10-15
- Last updated
- 2020-04-14
Locations
20 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03705013. Inclusion in this directory is not an endorsement.